Ping An

10PUBLICATIONS
15CO-AUTHORS
Liquid biopsiesNutritional epidemiologyChinese languagesTraditional Chinese medicine and treatmentsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Dec 12, 2025
A novel cell-permeable LOXL2 inhibitor PAT-1251 potently suppresses biliary liver fibrosis via collagen crosslinking-dependent and -independent mechanisms.

Ping An, Guangyan Wei, Pinzhu Huang

|Aug 20, 2025
Combined Biologics and Exclusive Enteral Nutrition Promote Early Transmural Healing and Improve Long-Term Outcomes in Crohn's Disease: A Multicenter Retrospective Study.

Haixia Ren, Jing An, Wei Chen

|Apr 17, 2025
Pancreatic Enzyme Replacement Therapy Improves Exclusive Enteral Nutrition Related Diarrhea in Crohn's Disease: A Prospective Randomized Trial.

Jian Kang, Jing Wang, Juan Su

|Feb 05, 2024
Psychological symptoms and quality of life in patients with inflammatory bowel disease in China: A multicenter study.

Jixiang Zhang, Chuan Liu, Ping An

|Nov 03, 2023
An education-based telehealth group improves the management and clinical outcomes of patients with inflammatory bowel disease in China (THEIM study).

Jian Kang, Juan Su, Jing Wang

|Aug 24, 2023
Efficacy of Ustekinumab Optimization by 2 Initial Intravenous Doses in Adult Patients With Severe Crohn's Disease.

Haixia Ren, Jian Kang, Jing Wang

Pageof 2

Frequent Collaborators

2 joint publications

Pinzhu Huang

2 joint publications

Yury V Popov

1 joint publications

Weiguo Dong

1 joint publications

Chuan Liu